Prostate cancer occurs only in males when cells in their prostate gland begin to multiply unchecked. The prostate gland is responsible for making some of the fluid in semen. Most prostate cancer cells grow slowly, but some grow quickly and spread to other parts of the body.

The specialists in GW Cancer Center’s Urologic Oncology program offer leading edge cancer detection tools and genetic tests to improve diagnosis and enhance treatments.

Specialty Care for Bladder Cancer

Our cancer specialists will help you understand your cancer diagnosis and determine the best treatment plan. Sometimes the best approach is to monitor slow-growing prostate cancers. 

Our program offers a clinic where patients can meet with several specialists in a single visit. Using advanced screening options, our specialists work together to accurately diagnosis the type of prostate cancer. We then create a treatment plan most likely to offer the best outcome for each patient. Treatments may include participation in life-saving clinical trials.

Bladder Cancer Program Information

Collaborative Care

Patient navigators support patients who have been diagnosed with prostate cancer. Navigators steer patients through the process. They even help them with the financial aspects of a cancer diagnosis, such as working with insurers.

Patients can conveniently interact with several specialists in one visit through our multidisciplinary clinic. Our team works together to provide an accurate diagnosis and to create the best treatment plan.

Patients who have received a diagnosis of prostate cancer should promptly consult our male fertility specialists prior to undergoing treatment. . You can contact a specialist at saveyoursperm@mfa.gwu.edu and expect a prompt response. Our specialists will provide a quick evaluation and options for fertility preservation. You can then begin cancer treatment with little or no delay confident that children can be in your future.

Clinical Research

Patients in clinical trials benefit from the latest developments in the field.

GW Cancer Center partners with these organizations to offer clinical trials for patients with bladder cancer:

  • The Genitourinary Multidisciplinary D.C. Regional Oncology Project (GUMDROP)
  • The National Cancer Institute (NCI) at the National Institutes of Health (NIH)
  • GW Cancer Center partners with the Eastern Cooperative Oncology Group (ECOG) to study new treatments for testicular cancer.
‌Advanced Diagnosis and Treatment

There are several cancer detection tools and tests that are available. We offer:

  • The Oncotype DX prostate cancer test to predict how aggressive the cancer will be. This helps us better determine the right treatment approach.
  • Decipher gene testing following prostate surgery. It categorizes risk and identifies which additional treatments will be necessary to avoid a recurrence or spreading of cancer.
  • Genetic testing for someone who has been diagnosed at a young age or who has a strong family history. Genetic testing can benefit the patient as well as their family – children and grandchildren – so they know if they are at risk for the disease and can take measures to avoid it.
‌Leading Edge Technology

GW Cancer Center invests in state-of-the-art technologies for cancer diagnosis and treatment:

  • The da Vinci® robotic surgical system offers surgeons more precision to minimize potential side effects. GW Cancer Center was the first in the region to use the da Vinci® robot for the management of prostate cancer. We have performed the highest number of robotic cases in the greater Washington, D.C., area.
  • The UroNav Fusion biopsy platform combines pre-biopsy magnetic resonance images (MRI) with ultrasound images to accurately guide a biopsy needle in real time. The system provides excellent visuals of the prostate gland and the needle. It results in better tissue collection.

Prostate Cancer is treated within the GW Urological Oncology Program

Photo of doctor
  • Multi-Disciplinary, Patient Centered Cancer Care
  • The GW Cancer Center offers advanced treatment in urology, including minimally invasive, laparoscopic surgery for the management of urinary, prostate, kidney, and pelvic disorders.

Urological Oncology Program Information

Urology is the branch of medicine that focuses on diseases of the male and female urinary tract system and the male reproductive organs. Urologic organs include the kidneys, adrenal glands, ureters, urinary bladder, urethra. The male reproductive organs include testicles, prostate, penis, and others.

Our program provides advanced diagnosis and treatment for patients with a urology cancer.

Research-based, Patient-Centered Cancer Care

The GW Cancer Center invests in research that will lead to future treatments and cures. As part of this, we’ve created a tissue bank for prostate, bladder, kidney, and testicular cancer. When new treatments become available, we will study them using saved tissue. The results translate into knowledge of which treatments work best for each tissue type.

This effort will lead to more individualized medicine. This is the future of cancer treatment. We will be able to offer better results when treatment plans are based on an individual’s genetics. 

Collaborative Care

We offer a multidisciplinary clinic where patients can conveniently interact with several specialists in one visit. Our team works together to provide an accurate diagnosis and to create the best treatment plan. Patients benefit when great minds collaborate on diagnosis and treatment options.

Patients who have received a diagnosis of testicular cancer should promptly consult our male fertility specialists prior to undergoing treatment. You can contact a specialist at saveyoursperm@mfa.gwu.edu and expect a prompt response. Our specialists will provide a quick evaluation and options for fertility preservation. You can then begin cancer treatment with little or no delay, confident that you have taken every step possible to allow yourself the option of children in your future.

Patient navigators support patients who have been diagnosed with cancer. Navigators steer patients through the process. They even help them with the financial aspects of a cancer diagnosis, such as working with insurers.

Clinical Research

Patients in clinical trials benefit from the latest developments in the field.

GW Cancer Center partners with these organizations to offer clinical trials for patients with urologic cancer:

  • The Genitourinary Multidisciplinary D.C. Regional Oncology Project (GUMDROP)
  • The National Cancer Institute (NCI) at the National Institutes of Health (NIH)
  • The Eastern Cooperative Oncology Group (ECOG)
Advanced Diagnosis and Treatment

GW Cancer Center offers specialized screening and treatment for urologic cancers:

  • The Oncotype DX prostate cancer test predicts how aggressive the cancer will be. This helps us better determine the right treatment approach.
  • Decipher gene testing following prostate surgery categorizes risk. It identifies which treatments will be necessary to avoid a recurrence or spreading of cancer.
  • For any cancer where systemic therapy is needed, we offer a specialized sperm analysis and retrieval procedure. This obtains viable sperm that can be stored and used after cancer treatment is complete.
  • Some men with testicular cancer will be eligible for partial removal of the testicle (partial orchiectomies).
  • Hormone therapies protect sexual health and performance in men after cancer treatment.
  • We offer a reconstructive surgical procedure to divert urine out of the body for patients whose bladder has been removed.
Leading Edge Technology

GW Cancer Center invests in state-of-the-art technologies for cancer diagnosis and treatment:

  • GW was the first in the area to use the da Vinci® robot for minimally invasive urologic surgery. We have performed the highest number of robotic cases in the greater Washington, D.C., area.
  • Cysview® Blue Light Cystoscopy increases detection of cancer by using a special dye that can be better seen in cancer cells. This technology is helping to decrease the recurrence rate of cancer by catching recurrent tumors in the earliest stages.
  • Urovysion™ Fluorescence In Situ Hybridization (FISH) gives researchers a way to map an individual’s genetic material with a urine sample. We use this information to determine if cancer-causing genetic problems exist.
  • The UroNav Fusion biopsy platform combines pre-biopsy magnetic resonance images (MRI) with ultrasound images to accurately guide a biopsy needle in real time. The system provides excellent visuals of the prostate gland and the needle. It results in better tissue collection.

Urological Oncology Program Providers

Specialty: Urology
Specialty: Urology
Specialty: Center for Sexual Health, Prostate Cancer Clinic, Urology
Specialty: Urology
Specialty: Minimally Invasive Surgery, Robotic Surgery, Urology
Specialty: Cancer & Blood Disorders
Specialty: Urology
Specialty: General Surgery, Transplant Services
Specialty: Breast Center, Prostate, Prostate Cancer Clinic, Radiation Oncology, Radiology
Specialty: Center for Pelvic Health, Center for Sexual Health, Doctors International, Minimally Invasive Surgery, Urology
Specialty: Urology
Specialty: Urology